Clinical Trial Update: Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

View source ↗

Summary

MeiraGTx is conducting a long-term follow-up study of the AAV2hAQP1 gene therapy for radiation-induced Xerostomia. The trial is listed as active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Xerostomia

Drugs mentioned

• AAV2hAQP1 (AAV2hAQP1 gene therapy)

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Radiation-induced Xerostomia | Status: ACTIVE_NOT_RECRUITING